Jinxin oral liquid reduced lung inflammation in influenza A virus infected mice through inhibiting NOD-like receptor protein 3 pathway.
These findings suggest that JX holds promise as a potential therapeutic agent for suppressing the aggressive pro-inflammatory response induced by H1N1 infection. Further research and development are warranted to explore the full potential of JX in the prevention and treatment of H1N1 infection.
Authors
- Jianjian Ji (ORCID: https://orcid.org/0000-0002-4336-0589)
- Shouchuan Wang (ORCID: https://orcid.org/0009-0002-2051-3420)
- Tao Li (ORCID: https://orcid.org/0000-0001-6161-7352)
- Xianzheng Wang (ORCID: https://orcid.org/0000-0003-3435-3747)
- Qigang Dai (ORCID: https://orcid.org/0000-0003-0716-1264)
- Xiong Yingcai
Institutions
- Nanjing University of Chinese Medicine (CN)
- Hebei University of Chinese Medicine (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.19852/j.cnki.jtcm.2025.02.022
- Primary Topic
- Herbal Medicine Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00